Literature DB >> 19289394

Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.

A Ghalamkarpour1, W Holnthoner, P Saharinen, L M Boon, J B Mulliken, K Alitalo, M Vikkula.   

Abstract

BACKGROUND: Heterozygous mutations in VEGFR3 have been identified in some familial cases with dominantly inherited primary congenital lymphoedema, known as Nonne-Milroy disease. Recessive cases of primary lymphoedema with a genetic cause are not known, except for two families with syndromic hypotrichosis-lymphoedema-telangiectasia, with a SOX18 mutation. METHODS AND
RESULTS: In this study, we present the first case of isolated primary congenital lymphoedema with recessive inheritance, caused by a homozygous mutation in VEGFR3. The novel mutation is a transition from alanine-to-threonine in amino acid 855, located in the ATP binding domain of the VEGFR3 receptor. Assessment of receptor function showed impaired ligand induced internalisation and ERK1/2 activity. Moreover, receptor phosphorylation was reduced, although less so than for a kinase-dead VEGFR3 mutation, which causes Nonne-Milroy disease.
CONCLUSION: A hypomorphic VEGFR3 mutation, with moderate effect on receptor function, in a homozygous state can result in insufficient lymphatic functioning. Thus, in addition to Nonne-Milroy disease with dominant inheritance, VEGFR3 alterations can cause isolated recessive primary congenital lymphoedema. These data expand our understanding of the aetiology of congenital lymphoedema and suggest that large scale screening of VEGFR3 in all primary lymphoedema patients is necessary.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289394     DOI: 10.1136/jmg.2008.064469

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

Review 1.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

Review 2.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

3.  Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations.

Authors:  M Alders; A Mendola; L Adès; L Al Gazali; C Bellini; B Dallapiccola; P Edery; U Frank; F Hornshuh; S A Huisman; S Jagadeesh; H Kayserili; W T Keng; D Lev; C E Prada; J R Sampson; J Schmidtke; V Shashi; Y van Bever; N Van der Aa; J M Verhagen; J B Verheij; M Vikkula; R C Hennekam
Journal:  Mol Syndromol       Date:  2012-10-02

4.  Novel zebrafish model reveals a critical role for MAPK in lymphangiogenesis.

Authors:  R Dawn Fevurly; Sean Hasso; Alexander Fye; Steven J Fishman; Joanne Chan
Journal:  J Pediatr Surg       Date:  2012-01       Impact factor: 2.545

Review 5.  Intestinal lymphatic vasculature: structure, mechanisms and functions.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-28       Impact factor: 46.802

Review 6.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 7.  Genetics of lymphatic anomalies.

Authors:  Pascal Brouillard; Laurence Boon; Miikka Vikkula
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

8.  Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.

Authors:  A Mendola; M J Schlögel; A Ghalamkarpour; A Irrthum; H L Nguyen; E Fastré; A Bygum; C van der Vleuten; C Fagerberg; E Baselga; I Quere; J B Mulliken; L M Boon; P Brouillard; M Vikkula
Journal:  Mol Syndromol       Date:  2013-08-21

9.  Primary versus trauma-induced Gorham-Stout disease.

Authors:  N Tanoue; L Moedano; M Witte; M Montague; A Lukefahr; M Bernas
Journal:  Lymphology       Date:  2018       Impact factor: 1.286

10.  VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

Authors:  Tuomas Tammela; Georgia Zarkada; Harri Nurmi; Lars Jakobsson; Krista Heinolainen; Denis Tvorogov; Wei Zheng; Claudio A Franco; Aino Murtomäki; Evelyn Aranda; Naoyuki Miura; Seppo Ylä-Herttuala; Marcus Fruttiger; Taija Mäkinen; Anne Eichmann; Jeffrey W Pollard; Holger Gerhardt; Kari Alitalo
Journal:  Nat Cell Biol       Date:  2011-09-11       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.